Terminal hairs growing in, but derm still says I’m going to go bald in the years to come??
    Chat 5/20/2025

    From the encyclopedia
    Vitamin D →

    Vitamin made in the skin from sunlight, also taken as a supplement

    Minoxidil →

    Vasodilator used on the scalp and, at low doses, as a tablet

    Spironolactone →

    Blood-pressure and diuretic drug with anti-androgen effects

    At a glance
    In this treatment experience post, the primary subjects mentioned are the tone is confused with some growth results.

    Other terms

    A 30-year-old woman with a history of anemia and low vitamin D experienced hair shedding, which improved after addressing nutrient deficiencies. Despite regrowth of terminal hairs, her dermatologist recommended treatments like minoxidil and spironolactone to prevent future bald spots, but she is cautious due to family history of hormone-related cancers.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

      community Thoughts on the future of pp405?

       43 upvotes 10 months ago
      PP405 is considered a promising hair loss treatment, potentially replacing minoxidil but not finasteride. Users are hopeful for future treatments like GT20029 and VDPHL01, while remaining cautious about effectiveness and side effects.

      community 30-Min Dermatology Visit – Best Questions to Ask About Balding? ( 175$ )

       6 upvotes 1 year ago
      The conversation discusses hair loss treatments, focusing on finasteride, minoxidil, and other options like PRP and ketoconazole. It highlights the importance of asking specific questions during a dermatology visit to determine the cause of hair loss and appropriate treatments.

      community Will PP405 need to be used indefinitely, like minoxidil?

       31 upvotes 11 months ago
      PP405 may not need daily use like minoxidil, but finasteride might still be needed to maintain hair regrowth. PP405 reawakens dormant hair follicles, potentially offering a long-term solution, though not a permanent cure.

      community Turning vellus hairs into terminal hair

      in Research/Science  12 upvotes 1 year ago
      People are discussing hair loss treatments, including minoxidil, finasteride, and RU58841, to turn vellus hairs into terminal hairs. Some users also mention using antibiotics, oral minoxidil, dutasteride, DHT blockers, biotin, and natural remedies like onion juice and seeds to improve hair growth.

    Related Research

    6 / 6 results

      research Telogen Effluvium

      July 2018 in “Elsevier eBooks”
      This review discusses telogen effluvium, a common form of hair loss, and reports no new clinical results; the authors outline possible causes, typical prognosis, and management strategies.

      research Telogen effluvium

      67 citations , January 2013 in “Indian Journal of Dermatology, Venereology and Leprology”
      This review discusses telogen effluvium, a common type of hair loss, focusing on differentiation from other conditions and potential causes, but presents no new research findings.

      research Acute Versus Chronic Telogen Hair Loss: A Review of the Knowledge and Recent Facts

      June 2024 in “Al- Anbar Medical Journal”
      This review discusses the mechanisms, causes, and treatment options for telogen effluvium, noting acute cases often resolve by addressing causative factors, while chronic forms remain challenging to treat; recent causes include post-hair transplantation, vitamin D deficiency, and COVID-19.

      research The Role of Vitamins and Minerals in Hair Loss: A Review

      134 citations , December 2018 in “Dermatology and Therapy”
      This review discusses the potential role of vitamins and minerals in managing non-scarring alopecia but reports no clinical results; the authors advocate for further controlled trials to explore these relationships.

      research Shedding: How to manage a common cause of hair loss

      34 citations , March 2001 in “Cleveland Clinic Journal of Medicine”
      This article reviews the triggers, diagnosis, and management of telogen effluvium in men and women, emphasizing the role of patient education and reassurance, but presents no new clinical findings.